23 Sep - 2 min read

Voluntary Announcement Relating To Medicare Acquisition

Voluntary Announcement Relating To Medicare Acquisition

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
Share code: DCP
ISIN: ZAE000227831
("Dis-Chem" or "the Company" or "the Group")

VOLUNTARY ANNOUNCEMENT RELATING TO MEDICARE ACQUISITION

Shareholders are referred to the announcement released by Dis-Chem on 21 December 2020 wherein it was
communicated that it had entered into a binding agreement (the "Agreement") with Pure Pharmacy Holdings
and its existing shareholders, in terms of which it will acquire 100% of the issued share capital in and shareholder
claims of Pure Pharmacy Holdings (Proprietary) Limited, trading as Medicare Health ("Medicare”) (“the
Transaction”).

Dis-Chem is pleased to announce that all conditions precedent have been met and that this Transaction has
been completed. Approval by the Competition Tribunal for the Transaction was received on 20 September 2021.
The effective date for the Transaction will be 1 October 2021.

This Transaction accelerates the growth of Dis-Chem’s store network, presenting the Group with access to
several new markets in geographies where Dis-Chem is currently under-represented. For the 12-months ended
28 February 2021, Medicare generated revenue of R1.1bn, with dispensary contributing two thirds.

Dis-Chem will pay a final purchase consideration of approximately R250m, subject to final net working capital
guarantee calculations upon closure.

The transaction mentioned in this announcement is not deemed to be a categorised transaction in terms of the
Listings Requirements of the JSE Limited.



Midrand
23 September 2021

Sponsor
The Standard Bank of South Africa Limited

Date: 23-09-2021 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Dis-Chem Pharmacies Limited (JSE:DCP) when you join Listcorp.